Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
27 Nov 2024
Bicaval TricValve Tricuspid Regurgitation: Late-Breaking PCR London Valves 2024
Bicaval TricValve shows safety, improves symptoms, and reduces hospitalisations in patients with severe tricuspid regurgitation.
27 Nov 2024
MiCLASP Study Two-Year Outcomes: Late-Breaking PCR London Valves 2024
The MiCLASP study highlights the PASCAL system’s sustained safety and effectiveness in reducing mitral regurgitation at two years.
26 Nov 2024
Spinal Cord Stimulation Superior to Conventional Treatments for Chronic Pain
Spinal cord stimulation outperforms conventional medical management for chronic pain relief, improving pain intensity, quality of life, and disability at six months.
26 Nov 2024
J-valve for Aortic Regurgitation: Late-Breaking PCR London Valves 2024
A multicentre study shows safety and success rates for the transfemoral J-valve in severe aortic regurgitation.
26 Nov 2024
TRISCEND II Trial: Late-Breaking PCR London Valves 2024
Study confirms transcatheter tricuspid-valve replacement improves symptoms, quality of life in severe tricuspid regurgitation patients.
25 Nov 2024
TriCLASP Study: Late-Breaking PCR London Valves 2024
PASCAL repair reduces severe TR, improves survival, heart failure hospitalisations, and quality of life at one year.
24 Nov 2024
AI Revolutionises Early Detection of Liver Disease
A new study reveals that AI can identify early-stage metabolic-associated steatotic liver disease using electronic health records.
24 Nov 2024
Left Atrial Stiffness Index: A Breakthrough in Heart Failure Management
LA stiffness index correlates strongly with LVFPs in acute heart failure, showing superior diagnostic accuracy over standard measures, with potential to improve non-invasive management strategies.
24 Nov 2024
Paediatric-Onset Behçet’s Disease Often Worsens in Adulthood
One-third of paediatric Behçet’s disease patients face new complications or relapses in adulthood, highlighting the need for lifelong care.
24 Nov 2024
Preterm Birth Linked to School-Age Neurodevelopmental Challenges
Children born moderate to late preterm exhibit poorer cognitive and academic performance, and more behavioural difficulties at school age.
←
1
2
3
…
32
33
34
35
36
37
38
…
48
49
50
→
We’ve noticed you’re accessing
from
North/South America.
View
View